Table of Contents Europe Diabetic Gastroparesis Treatment Market Report 2012-2023 1 Diabetic Gastroparesis Treatment Overview 1.1 Product Overview and Scope of Diabetic Gastroparesis Treatment 1.2 Classification of Diabetic Gastroparesis Treatment by Product Category 1.2.1 Europe Diabetic Gastroparesis Treatment Sales (K Units) Comparison by Types (2012-2023) 1.2.2 Europe Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Types in 2017 1.2.3 Gastroprokinetic Agents 1.2.4 Antiemetic Agents 1.2.5 Botulinum Toxin 1.3 Europe Diabetic Gastroparesis Treatment Market by Application/End Users 1.3.1 Europe Diabetic Gastroparesis Treatment (K Units) and Market Share Comparison by Applications (2012-2023) 1.3.2 Compensated Gastroparesis 1.3.3 Gastric Failure 1.3.4 Others 1.4 Europe Diabetic Gastroparesis Treatment Market by Region 1.4.1 Europe Diabetic Gastroparesis Treatment Revenue (Million USD) Comparison by Regions (2012-2023) 1.4.2 Germany Status and Prospect (2012-2023) 1.4.3 UK Status and Prospect (2012-2023) 1.4.4 France Status and Prospect (2012-2023) 1.4.5 Russia Status and Prospect (2012-2023) 1.4.6 Benelux Status and Prospect (2012-2023) 1.4.7 Italy Status and Prospect (2012-2023) 1.4.8 Spain Status and Prospect (2012-2023) 1.5 Europe Sales and Revenue ofSales and Revenue of Diabetic Gastroparesis Treatment (2012-2023) 1.5.1 Europe Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate (2012-2023) 1.5.2 Europe Diabetic Gastroparesis Treatment Revenue (Million USD) and Growth Rate (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Diabetic Gastroparesis Treatment 2.2 Raw Material Analysis of Diabetic Gastroparesis Treatment 2.1.1 Raw Material A Market Analysis 2.1.2 Raw Material B Market Analysis 2.1.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Diabetic Gastroparesis Treatment 2.4 Other Costs Analysis of Diabetic Gastroparesis Treatment 2.5 Manufacturing Cost Structure Analysis of Diabetic Gastroparesis Treatment 2.6 Manufacturing Process Analysis of Diabetic Gastroparesis Treatment 2.7 Raw Materials Sources of Diabetic Gastroparesis Treatment Major Manufacturers in 2018 2.8 Downstream Buyers 3 Europe Diabetic Gastroparesis Treatment Players/Suppliers Profiles and Sales Data 3.1 Janssen Global Services, LLC 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Diabetic Gastroparesis Treatment Product Category, Application and Specification 3.1.2.1 Product A 3.1.2.2 Product B 3.1.3 Janssen Global Services, LLC Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Janssen Global Services, LLC Different Types of Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.1.5 Janssen Global Services, LLC Diabetic Gastroparesis Treatment Volume in Different Applications and Its Application Share 3.2 Evoke Pharma 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Diabetic Gastroparesis Treatment Product Category, Application and Specification 3.2.2.1 Product A 3.2.2.2 Product B 3.2.3 Evoke Pharma Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 Evoke Pharma Different Types of Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.2.5 Evoke Pharma Diabetic Gastroparesis Treatment Volume in Different Applications and Its Application Share 3.3 Cardinal Health, Inc. 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Diabetic Gastroparesis Treatment Product Category, Application and Specification 3.3.2.1 Product A 3.3.2.2 Product B 3.3.3 Cardinal Health, Inc. Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 Cardinal Health, Inc. Different Types of Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.3.5 Cardinal Health, Inc. Diabetic Gastroparesis Treatment Volume in Different Applications and Its Application Share 3.4 Salix Pharmaceuticals, Inc. 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Diabetic Gastroparesis Treatment Product Category, Application and Specification 3.4.2.1 Product A 3.4.2.2 Product B 3.4.3 Salix Pharmaceuticals, Inc. Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Salix Pharmaceuticals, Inc. Different Types of Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.4.5 Salix Pharmaceuticals, Inc. Diabetic Gastroparesis Treatment Volume in Different Applications and Its Application Share 3.5 Alfa Wassermann SPA 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Diabetic Gastroparesis Treatment Product Category, Application and Specification 3.5.2.1 Product A 3.5.2.2 Product B 3.5.3 Alfa Wassermann SPA Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Alfa Wassermann SPA Different Types of Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.5.5 Alfa Wassermann SPA Diabetic Gastroparesis Treatment Volume in Different Applications and Its Application Share 3.6 Abbott Laboratories 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Diabetic Gastroparesis Treatment Product Category, Application and Specification 3.6.2.1 Product A 3.6.2.2 Product B 3.6.3 Abbott Laboratories Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Abbott Laboratories Different Types of Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.6.5 Abbott Laboratories Diabetic Gastroparesis Treatment Volume in Different Applications and Its Application Share 3.7 Medtronic Plc. 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Diabetic Gastroparesis Treatment Product Category, Application and Specification 3.7.2.1 Product A 3.7.2.2 Product B 3.7.3 Medtronic Plc. Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Medtronic Plc. Different Types of Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.7.5 Medtronic Plc. Diabetic Gastroparesis Treatment Volume in Different Applications and Its Application Share 3.8 C. R. Bard, Inc. 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Diabetic Gastroparesis Treatment Product Category, Application and Specification 3.8.2.1 Product A 3.8.2.2 Product B 3.8.3 C. R. Bard, Inc. Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 C. R. Bard, Inc. Different Types of Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.8.5 C. R. Bard, Inc. Diabetic Gastroparesis Treatment Volume in Different Applications and Its Application Share 3.9 Rhythm Pharmaceuticals, Inc. 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Diabetic Gastroparesis Treatment Product Category, Application and Specification 3.9.2.1 Product A 3.9.2.2 Product B 3.9.3 Rhythm Pharmaceuticals, Inc. Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 Rhythm Pharmaceuticals, Inc. Different Types of Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.9.5 Rhythm Pharmaceuticals, Inc. Diabetic Gastroparesis Treatment Volume in Different Applications and Its Application Share 3.10 Boston Scientific Corporation 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Diabetic Gastroparesis Treatment Product Category, Application and Specification 3.10.2.1 Product A 3.10.2.2 Product B 3.10.3 Boston Scientific Corporation Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.4 Boston Scientific Corporation Different Types of Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.10.5 Boston Scientific Corporation Diabetic Gastroparesis Treatment Volume in Different Applications and Its Application Share 3.11 Kimberly-Clark Corporation 4 Europe Diabetic Gastroparesis Treatment Competition by Players/Manufacturers, Region, Type and Application 4.1 Europe Diabetic Gastroparesis Treatment Market Competition by Players/Manufacturers 4.1.1 Europe Diabetic Gastroparesis Treatment Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017) 4.1.2 Europe Diabetic Gastroparesis Treatment Revenue (Million USD) and Share by Players/Suppliers (2012-2017) 4.2 Europe Diabetic Gastroparesis Treatment Sales and Revenue by Type 4.2.1 Europe Diabetic Gastroparesis Treatment Sales (K Units) and Market Share by Type (2012-2017) 4.2.2 Europe Diabetic Gastroparesis Treatment Revenue (Million USD) and Market Share by Type (2012-2017) 4.3 Europe Diabetic Gastroparesis Treatment Sales and Revenue by Application 4.3.1 Europe Diabetic Gastroparesis Treatment Sales (K Units) and Market Share by Regions (2012-2017) 4.3.2 Europe Diabetic Gastroparesis Treatment Revenue (Million USD) and Market Share (%) Regions (2012-2017) 4.4 Europe Diabetic Gastroparesis Treatment Sales (K Units) by Application 5 Germany Diabetic Gastroparesis Treatment (Sales, Revenue and Price) 5.1 Germany Diabetic Gastroparesis Treatment Sales and Value (2012-2017) 5.1.1 Germany Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate (2012-2017) 5.1.2 Germany Diabetic Gastroparesis Treatment Revenue and Growth Rate (2012-2017) 5.1.3 Germany Diabetic Gastroparesis Treatment Sales Price (USD/Unit) Trend (2012-2017) 5.2 Germany Diabetic Gastroparesis Treatment Sales (K Units) and Market Share by Type 5.3 Germany Diabetic Gastroparesis Treatment Sales (K Units) and Market Share by Application 6 UK Diabetic Gastroparesis Treatment (Sales, Revenue and Price) 6.1 UK Diabetic Gastroparesis Treatment Sales and Value (2012-2017) 6.1.1 UK Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate (2012-2017) 6.1.2 UK Diabetic Gastroparesis Treatment Revenue and Growth Rate (2012-2017) 6.1.3 UK Diabetic Gastroparesis Treatment Sales Price (USD/Unit) Trend (2012-2017) 6.2 UK Diabetic Gastroparesis Treatment Sales (K Units) and Market Share by Type 6.3 UK Diabetic Gastroparesis Treatment Sales (K Units) and Market Share by Application 7 France Diabetic Gastroparesis Treatment (Sales, Revenue and Price) 7.1 France Diabetic Gastroparesis Treatment Sales and Value (2012-2017) 7.1.1 France Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate (2012-2017) 7.1.2 France Diabetic Gastroparesis Treatment Revenue and Growth Rate (2012-2017) 7.1.3 France Diabetic Gastroparesis Treatment Sales Price (USD/Unit) Trend (2012-2017) 7.2 France Diabetic Gastroparesis Treatment Sales (K Units) and Market Share by Type 7.3 France Diabetic Gastroparesis Treatment Sales (K Units) and Market Share by Application 8 Russia Diabetic Gastroparesis Treatment (Sales, Revenue and Price) 8.1 Russia Diabetic Gastroparesis Treatment Sales and Value (2012-2017) 8.1.1 Russia Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate (2012-2017) 8.1.2 Russia Diabetic Gastroparesis Treatment Revenue and Growth Rate (2012-2017) 8.1.3 Russia Diabetic Gastroparesis Treatment Sales Price (USD/Unit) Trend (2012-2017) 8.2 Russia Diabetic Gastroparesis Treatment Sales (K Units) and Market Share by Type 8.3 Russia Diabetic Gastroparesis Treatment Sales (K Units) and Market Share by Application 9 Benelux Diabetic Gastroparesis Treatment (Sales, Revenue and Price) 9.1 Benelux Diabetic Gastroparesis Treatment Sales and Value (2012-2017) 9.1.1 Benelux Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate (2012-2017) 9.1.2 Benelux Diabetic Gastroparesis Treatment Revenue and Growth Rate (2012-2017) 9.1.3 Benelux Diabetic Gastroparesis Treatment Sales Price (USD/Unit) Trend (2012-2017) 9.2 Benelux Diabetic Gastroparesis Treatment Sales (K Units) and Market Share by Type 9.3 Benelux Diabetic Gastroparesis Treatment Sales (K Units) and Market Share by Application 10 Italy Diabetic Gastroparesis Treatment (Sales, Revenue and Price) 10.1 Italy Diabetic Gastroparesis Treatment Sales and Value (2012-2017) 10.1.1 Italy Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate (2012-2017) 10.1.2 Italy Diabetic Gastroparesis Treatment Revenue and Growth Rate (2012-2017) 10.1.3 Italy Diabetic Gastroparesis Treatment Sales Price (USD/Unit) Trend (2012-2017) 10.2 Italy Diabetic Gastroparesis Treatment Sales (K Units) and Market Share by Type 10.3 Italy Diabetic Gastroparesis Treatment Sales (K Units) and Market Share by Application 11 Spain Diabetic Gastroparesis Treatment (Sales, Revenue and Price) 11.1 Spain Diabetic Gastroparesis Treatment Sales and Value (2012-2017) 11.1.1 Spain Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate (2012-2017) 11.1.2 Spain Diabetic Gastroparesis Treatment Revenue and Growth Rate (2012-2017) 11.1.3 Spain Diabetic Gastroparesis Treatment Sales Price (USD/Unit) Trend (2012-2017) 11.2 Spain Diabetic Gastroparesis Treatment Sales (K Units) and Market Share by Type 11.3 Spain Diabetic Gastroparesis Treatment Sales (K Units) and Market Share by Application 12 Marketing Strategy Analysis, Distributors/Traders 12.1 Direct Marketing 12.1.1 Direct Marketing 12.1.2 Indirect Marketing 12.1.3 Marketing Channel Development Trend 12.2 Market Positioning 12.2.1 Pricing Strategy 12.2.2 Brand Strategy 12.2.3 Target Client 12.3 Distributors/Traders List 13 Europe Diabetic Gastroparesis Treatment Market Forecast (2018-2023) 13.1 Europe Diabetic Gastroparesis Treatment Sales (K Units), Revenue and Price Forecast (2018-2023) 13.1.1 Europe Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate Forecast (2018-2023) 13.1.2 Europe Diabetic Gastroparesis Treatment Revenue and Growth Rate Forecast (2018-2023) 13.1.3 Europe Diabetic Gastroparesis Treatment Price and Trend Forecast (2018-2023) 13.2 Europe Diabetic Gastroparesis Treatment Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.1 Europe Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate Forecast by Region (2018-2023) 13.2.2 Europe Diabetic Gastroparesis Treatment Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.3 Germany Diabetic Gastroparesis Treatment Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.4 UK Diabetic Gastroparesis Treatment Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.5 France Diabetic Gastroparesis Treatment Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.6 Russia Diabetic Gastroparesis Treatment Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.7 France Diabetic Gastroparesis Treatment Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.8 Italy Diabetic Gastroparesis Treatment Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.9 Spain Diabetic Gastroparesis Treatment Sales, Revenue and Growth Rate Forecast (2018-2023) 13.3 Europe Diabetic Gastroparesis Treatment Sales, Revenue and Price Forecast by Type (2018-2023) 13.3.1 Europe Diabetic Gastroparesis Treatment Sales Forecast by Type (2018-2023) 13.3.2 Europe Diabetic Gastroparesis Treatment Revenue Forecast by Type (2018-2023) 13.3.3 Europe Diabetic Gastroparesis Treatment Price Forecast by Type (2018-2023) 13.4 Europe Diabetic Gastroparesis Treatment Sales Forecast by Application (2018-2023) 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology/Research Approach 15.1.1 Research Programs/Design 15.1.2 Market Size Estimation 15.1.3 Market Breakdown and Data Triangulation 15.2 Data Source 15.2.1 Secondary Sources 15.2.2 Primary Sources 15.3 Disclaimer

List of Tables and Figures Figure Europe Market Size (Million USD) Comparison 2012-2023 Table Europe Market Diabetic Gastroparesis Treatment Revenue (Million USD) Comparison by Regions 2012-2023 Table Europe Diabetic Gastroparesis Treatment Sales (K Units) and Revenue (Million USD) Market Split by Product Type Table Europe Diabetic Gastroparesis Treatment Sales (K Units) by Application (2016-2023) Figure Product Picture of Diabetic Gastroparesis Treatment Table Europe Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure Europe Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Types in 2017 Figure Gastroprokinetic Agents Picture Figure Antiemetic Agents Picture Figure Botulinum Toxin Picture Table Europe Diabetic Gastroparesis Treatment Sales (K Units) Comparison by Applications (2012-2023) Figure Europe Sales Market Share of Diabetic Gastroparesis Treatment by Applications in 2017 Figure Compensated Gastroparesis Picture Figure Gastric Failure Picture Figure Others Picture Table Europe Market Diabetic Gastroparesis Treatment Revenue (Million USD) Comparison by Regions 2012-2023 Figure Germany Diabetic Gastroparesis Treatment Revenue (Million USD) and Growth Rate (2012-2023) Figure UK Diabetic Gastroparesis Treatment Revenue (Million USD) and Growth Rate (2012-2023) Figure France Diabetic Gastroparesis Treatment Revenue (Million USD) and Growth Rate (2012-2023) Figure Russia Diabetic Gastroparesis Treatment Revenue (Million USD) and Growth Rate (2012-2023) Figure Benelux Diabetic Gastroparesis Treatment Revenue (Million USD) and Growth Rate (2012-2023) Figure Italy Diabetic Gastroparesis Treatment Revenue (Million USD) and Growth Rate (2012-2023) Figure Spain Diabetic Gastroparesis Treatment Revenue (Million USD) and Growth Rate (2012-2023) Figure Europe Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate (2012-2023) Figure Europe Diabetic Gastroparesis Treatment Revenue (Million USD) and Growth Rate (2012-2023) Figure New Project SWOT Analysis of Diabetic Gastroparesis Treatment Table Industry News List of Diabetic Gastroparesis Treatment Figure Industry Chain Structure of Diabetic Gastroparesis Treatment Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Diabetic Gastroparesis Treatment in 2017 Figure Manufacturing Process Analysis of Diabetic Gastroparesis Treatment Table Raw Materials Sources of Diabetic Gastroparesis Treatment Major Manufacturers Europe Table Major Buyers of Diabetic Gastroparesis Treatment Table Janssen Global Services, LLC Basic Information List Table Janssen Global Services, LLC Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Janssen Global Services, LLC Diabetic Gastroparesis Treatment Sales Growth Rate (2012-2017) Figure Janssen Global Services, LLC Diabetic Gastroparesis Treatment Sales Europe Market Share (%) (2012-2017) Figure Janssen Global Services, LLC Diabetic Gastroparesis Treatment Revenue Europe Market Share (%) (2012-2017) Table Gastroprokinetic Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antiemetic Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Botulinum Toxin Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Janssen Global Services, LLC Diabetic Gastroparesis Treatment Volume in Compensated Gastroparesis and Its Application Share Table Janssen Global Services, LLC Diabetic Gastroparesis Treatment Volume in Gastric Failure and Its Application Share Table Janssen Global Services, LLC Diabetic Gastroparesis Treatment Volume in Others and Its Application Share Table Evoke Pharma Basic Information List Table Evoke Pharma Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Evoke Pharma Diabetic Gastroparesis Treatment Sales Growth Rate (2012-2017) Figure Evoke Pharma Diabetic Gastroparesis Treatment Sales Europe Market Share (%) (2012-2017) Figure Evoke Pharma Diabetic Gastroparesis Treatment Revenue Europe Market Share (%) (2012-2017) Table Gastroprokinetic Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antiemetic Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Botulinum Toxin Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Evoke Pharma Diabetic Gastroparesis Treatment Volume in Compensated Gastroparesis and Its Application Share Table Evoke Pharma Diabetic Gastroparesis Treatment Volume in Gastric Failure and Its Application Share Table Evoke Pharma Diabetic Gastroparesis Treatment Volume in Others and Its Application Share Table Cardinal Health, Inc. Basic Information List Table Cardinal Health, Inc. Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Cardinal Health, Inc. Diabetic Gastroparesis Treatment Sales Growth Rate (2012-2017) Figure Cardinal Health, Inc. Diabetic Gastroparesis Treatment Sales Europe Market Share (%) (2012-2017) Figure Cardinal Health, Inc. Diabetic Gastroparesis Treatment Revenue Europe Market Share (%) (2012-2017) Table Gastroprokinetic Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antiemetic Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Botulinum Toxin Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Cardinal Health, Inc. Diabetic Gastroparesis Treatment Volume in Compensated Gastroparesis and Its Application Share Table Cardinal Health, Inc. Diabetic Gastroparesis Treatment Volume in Gastric Failure and Its Application Share Table Cardinal Health, Inc. Diabetic Gastroparesis Treatment Volume in Others and Its Application Share Table Salix Pharmaceuticals, Inc. Basic Information List Table Salix Pharmaceuticals, Inc. Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Salix Pharmaceuticals, Inc. Diabetic Gastroparesis Treatment Sales Growth Rate (2012-2017) Figure Salix Pharmaceuticals, Inc. Diabetic Gastroparesis Treatment Sales Europe Market Share (%) (2012-2017) Figure Salix Pharmaceuticals, Inc. Diabetic Gastroparesis Treatment Revenue Europe Market Share (%) (2012-2017) Table Gastroprokinetic Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antiemetic Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Botulinum Toxin Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salix Pharmaceuticals, Inc. Diabetic Gastroparesis Treatment Volume in Compensated Gastroparesis and Its Application Share Table Salix Pharmaceuticals, Inc. Diabetic Gastroparesis Treatment Volume in Gastric Failure and Its Application Share Table Salix Pharmaceuticals, Inc. Diabetic Gastroparesis Treatment Volume in Others and Its Application Share Table Alfa Wassermann SPA Basic Information List Table Alfa Wassermann SPA Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Alfa Wassermann SPA Diabetic Gastroparesis Treatment Sales Growth Rate (2012-2017) Figure Alfa Wassermann SPA Diabetic Gastroparesis Treatment Sales Europe Market Share (%) (2012-2017) Figure Alfa Wassermann SPA Diabetic Gastroparesis Treatment Revenue Europe Market Share (%) (2012-2017) Table Gastroprokinetic Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antiemetic Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Botulinum Toxin Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Alfa Wassermann SPA Diabetic Gastroparesis Treatment Volume in Compensated Gastroparesis and Its Application Share Table Alfa Wassermann SPA Diabetic Gastroparesis Treatment Volume in Gastric Failure and Its Application Share Table Alfa Wassermann SPA Diabetic Gastroparesis Treatment Volume in Others and Its Application Share Table Abbott Laboratories Basic Information List Table Abbott Laboratories Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Abbott Laboratories Diabetic Gastroparesis Treatment Sales Growth Rate (2012-2017) Figure Abbott Laboratories Diabetic Gastroparesis Treatment Sales Europe Market Share (%) (2012-2017) Figure Abbott Laboratories Diabetic Gastroparesis Treatment Revenue Europe Market Share (%) (2012-2017) Table Gastroprokinetic Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antiemetic Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Botulinum Toxin Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Abbott Laboratories Diabetic Gastroparesis Treatment Volume in Compensated Gastroparesis and Its Application Share Table Abbott Laboratories Diabetic Gastroparesis Treatment Volume in Gastric Failure and Its Application Share Table Abbott Laboratories Diabetic Gastroparesis Treatment Volume in Others and Its Application Share Table Medtronic Plc. Basic Information List Table Medtronic Plc. Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Medtronic Plc. Diabetic Gastroparesis Treatment Sales Growth Rate (2012-2017) Figure Medtronic Plc. Diabetic Gastroparesis Treatment Sales Europe Market Share (%) (2012-2017) Figure Medtronic Plc. Diabetic Gastroparesis Treatment Revenue Europe Market Share (%) (2012-2017) Table Gastroprokinetic Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antiemetic Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Botulinum Toxin Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Medtronic Plc. Diabetic Gastroparesis Treatment Volume in Compensated Gastroparesis and Its Application Share Table Medtronic Plc. Diabetic Gastroparesis Treatment Volume in Gastric Failure and Its Application Share Table Medtronic Plc. Diabetic Gastroparesis Treatment Volume in Others and Its Application Share Table C. R. Bard, Inc. Basic Information List Table C. R. Bard, Inc. Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure C. R. Bard, Inc. Diabetic Gastroparesis Treatment Sales Growth Rate (2012-2017) Figure C. R. Bard, Inc. Diabetic Gastroparesis Treatment Sales Europe Market Share (%) (2012-2017) Figure C. R. Bard, Inc. Diabetic Gastroparesis Treatment Revenue Europe Market Share (%) (2012-2017) Table Gastroprokinetic Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antiemetic Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Botulinum Toxin Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table C. R. Bard, Inc. Diabetic Gastroparesis Treatment Volume in Compensated Gastroparesis and Its Application Share Table C. R. Bard, Inc. Diabetic Gastroparesis Treatment Volume in Gastric Failure and Its Application Share Table C. R. Bard, Inc. Diabetic Gastroparesis Treatment Volume in Others and Its Application Share Table Rhythm Pharmaceuticals, Inc. Basic Information List Table Rhythm Pharmaceuticals, Inc. Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Rhythm Pharmaceuticals, Inc. Diabetic Gastroparesis Treatment Sales Growth Rate (2012-2017) Figure Rhythm Pharmaceuticals, Inc. Diabetic Gastroparesis Treatment Sales Europe Market Share (%) (2012-2017) Figure Rhythm Pharmaceuticals, Inc. Diabetic Gastroparesis Treatment Revenue Europe Market Share (%) (2012-2017) Table Gastroprokinetic Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antiemetic Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Botulinum Toxin Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Rhythm Pharmaceuticals, Inc. Diabetic Gastroparesis Treatment Volume in Compensated Gastroparesis and Its Application Share Table Rhythm Pharmaceuticals, Inc. Diabetic Gastroparesis Treatment Volume in Gastric Failure and Its Application Share Table Rhythm Pharmaceuticals, Inc. Diabetic Gastroparesis Treatment Volume in Others and Its Application Share Table Company Boston Scientific Corporation Basic Information List Table Company Boston Scientific Corporation Diabetic Gastroparesis Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Company Boston Scientific Corporation Diabetic Gastroparesis Treatment Sales Growth Rate (2012-2017) Figure Company Boston Scientific Corporation Diabetic Gastroparesis Treatment Sales Europe Market Share (%) (2012-2017) Figure Company Boston Scientific Corporation Diabetic Gastroparesis Treatment Revenue Europe Market Share (%) (2012-2017) Table Gastroprokinetic Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antiemetic Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Botulinum Toxin Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Company Boston Scientific Corporation Diabetic Gastroparesis Treatment Volume in Compensated Gastroparesis and Its Application Share Table Company Boston Scientific Corporation Diabetic Gastroparesis Treatment Volume in Gastric Failure and Its Application Share Table Company Boston Scientific Corporation Diabetic Gastroparesis Treatment Volume in Others and Its Application Share Table Europe Diabetic Gastroparesis Treatment Sales (K Units) by Players/Manufacturers (2012-2017) Table Europe Diabetic Gastroparesis Treatment Sales Share (%) by Players/Manufacturers (2012-2017) Figure 2016 Europe Diabetic Gastroparesis Treatment Sales Market Share (%) by Players/Manufacturers Figure 2017 Europe Diabetic Gastroparesis Treatment Sales Share by Players/Manufacturers Table Europe Diabetic Gastroparesis Treatment Revenue (Million USD) by Players/Manufacturers (2012-2017) Table Europe Diabetic Gastroparesis Treatment Revenue Market Share (%) Players/Manufacturers (2012-2017) Figure 2016 Europe Diabetic Gastroparesis Treatment Revenue Market Share (%) Players Figure 2017 Europe Diabetic Gastroparesis Treatment Revenue Market Share (%) Players Table Europe Diabetic Gastroparesis Treatment Sales (K Units) and Market Share (%) by Type (2012-2017) Table Europe Diabetic Gastroparesis Treatment Sales Share by Type (2012-2017) Figure Sales Market Share of Diabetic Gastroparesis Treatment by Type (2012-2017) Figure Europe Diabetic Gastroparesis Treatment Sales Growth Rate (%) by Type (2012-2017) Table Europe Diabetic Gastroparesis Treatment Revenue (Million USD) and Market Share (%) Type (2012-2017) Table Europe Diabetic Gastroparesis Treatment Revenue Market Share (%) Type (2012-2017) Figure Revenue Market Share of Diabetic Gastroparesis Treatment by Type (2012-2017) Figure Europe Diabetic Gastroparesis Treatment Revenue Growth Rate by Type (2012-2017) Table Europe Diabetic Gastroparesis Treatment Sales (K Units) and Market Share by Regions (2012-2017) Table Europe Diabetic Gastroparesis Treatment Sales Share by Regions (2012-2017) Figure Sales Market Share of Diabetic Gastroparesis Treatment by Regions (2012-2017) Figure Europe Diabetic Gastroparesis Treatment Sales Market Share by Regions in 2017 Table Europe Diabetic Gastroparesis Treatment Revenue (Million USD) and Market Share by Regions (2012-2017) Table Europe Diabetic Gastroparesis Treatment Revenue Share (%) by Regions (2012-2017) Figure Revenue Market Share of Diabetic Gastroparesis Treatment by Regions (2012-2017) Figure Europe Diabetic Gastroparesis Treatment Revenue Market Share by Regions in 2017 Table Europe Diabetic Gastroparesis Treatment Sales (K Units) and Market Share by Application (2012-2017) Table Europe Diabetic Gastroparesis Treatment Sales Share (%) by Application (2012-2017) Figure Europe Diabetic Gastroparesis Treatment Sales Market Share by Application (2012-2017) Figure Europe Diabetic Gastroparesis Treatment Sales Market Share by Application (2012-2017) Figure Germany Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate (%) (2012-2017) Figure Germany Diabetic Gastroparesis Treatment Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Germany Diabetic Gastroparesis Treatment Sales Price (USD/Unit) Trend (2012-2017) Table Germany Diabetic Gastroparesis Treatment Sales (K Units) by Type (2012-2017) Table Germany Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Type (2012-2017) Figure Germany Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Type in 2017 Table Germany Diabetic Gastroparesis Treatment Sales (K Units) by Applications (2012-2017) Table Germany Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Applications (2012-2017) Figure Germany Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Applications in 2017 Figure UK Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate (2012-2017) Figure UK Diabetic Gastroparesis Treatment Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure UK Diabetic Gastroparesis Treatment Sales Price (USD/Unit) Trend (2012-2017) Table UK Diabetic Gastroparesis Treatment Sales (K Units) by Type (2012-2017) Table UK Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Type (2012-2017) Figure UK Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Type in 2017 Table UK Diabetic Gastroparesis Treatment Sales (K Units) by Applications (2012-2017) Table UK Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Applications (2012-2017) Figure UK Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Applications in 2017 Figure France Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate (2012-2017) Figure France Diabetic Gastroparesis Treatment Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure France Diabetic Gastroparesis Treatment Sales Price (USD/Unit) Trend (2012-2017) Table France Diabetic Gastroparesis Treatment Sales (K Units) by Type (2012-2017) Table France Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Type (2012-2017) Figure France Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Type in 2017 Table France Diabetic Gastroparesis Treatment Sales (K Units) by Applications (2012-2017) Table France Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Applications (2012-2017) Figure France Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Applications in 2017 Figure Russia Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate (2012-2017) Figure Russia Diabetic Gastroparesis Treatment Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Russia Diabetic Gastroparesis Treatment Sales Price (USD/Unit) Trend (2012-2017) Table Russia Diabetic Gastroparesis Treatment Sales (K Units) by Type (2012-2017) Table Russia Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Type (2012-2017) Figure Russia Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Type in 2017 Table Russia Diabetic Gastroparesis Treatment Sales (K Units) by Applications (2012-2017) Table Russia Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Applications (2012-2017) Figure Russia Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Applications in 2017 Figure Italy Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate (2012-2017) Figure Italy Diabetic Gastroparesis Treatment Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Italy Diabetic Gastroparesis Treatment Sales Price (USD/Unit) Trend (2012-2017) Table Italy Diabetic Gastroparesis Treatment Sales (K Units) by Type (2012-2017) Table Italy Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Type (2012-2017) Figure Italy Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Type in 2017 Table Italy Diabetic Gastroparesis Treatment Sales (K Units) by Applications (2012-2017) Table Italy Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Applications (2012-2017) Figure Italy Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Applications in 2017 Figure Benelux Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate (2012-2017) Figure Benelux Diabetic Gastroparesis Treatment Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Benelux Diabetic Gastroparesis Treatment Sales Price (USD/Unit) Trend (2012-2017) Table Benelux Diabetic Gastroparesis Treatment Sales (K Units) by Type (2012-2017) Table Benelux Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Type (2012-2017) Figure Benelux Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Type in 2017 Table Benelux Diabetic Gastroparesis Treatment Sales (K Units) by Applications (2012-2017) Table Benelux Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Applications (2012-2017) Figure Benelux Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Applications in 2017 Figure Spain Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate (2012-2017) Figure Spain Diabetic Gastroparesis Treatment Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Spain Diabetic Gastroparesis Treatment Sales Price (USD/Unit) Trend (2012-2017) Table Spain Diabetic Gastroparesis Treatment Sales (K Units) by Type (2012-2017) Table Spain Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Type (2012-2017) Figure Spain Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Type in 2017 Table Spain Diabetic Gastroparesis Treatment Sales (K Units) by Applications (2012-2017) Table Spain Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Applications (2012-2017) Figure Spain Diabetic Gastroparesis Treatment Sales (K Units) Market Share by Applications in 2017 Table Distributors/Traders List Figure Europe Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate Forecast (2018-2023) Figure Europe Diabetic Gastroparesis Treatment Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Europe Diabetic Gastroparesis Treatment Price and Trend Forecast (2018-2023) Table Europe Diabetic Gastroparesis Treatment Sales (K Units) Forecast by Regions (2018-2023) Figure Europe Diabetic Gastroparesis Treatment Sales (K Units) Market Share Forecast by Regions (2018-2023) Figure Europe Diabetic Gastroparesis Treatment Sales (K Units) Market Share Forecast by Regions in 2023 Table Europe Diabetic Gastroparesis Treatment Revenue (Million USD) Forecast by Regions (2018-2023) Figure Europe Diabetic Gastroparesis Treatment Revenue Market Share Forecast by Regions (2018-2023) Figure Europe Diabetic Gastroparesis Treatment Revenue Market Share Forecast by Regions in 2023 Figure Germany Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Germany Diabetic Gastroparesis Treatment Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure France Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure France Diabetic Gastroparesis Treatment Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure UK Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure UK Diabetic Gastroparesis Treatment Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Russia Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Russia Diabetic Gastroparesis Treatment Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Benelux Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Benelux Diabetic Gastroparesis Treatment Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Italy Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Italy Diabetic Gastroparesis Treatment Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Spain Diabetic Gastroparesis Treatment Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Spain Diabetic Gastroparesis Treatment Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Table Europe Diabetic Gastroparesis Treatment Sales (K Units) Forecast by Type (2018-2023) Figure Europe Diabetic Gastroparesis Treatment Sales Market Share Forecast by Type (2018-2023) Table Europe Diabetic Gastroparesis Treatment Revenue (Million USD) Forecast by Type (2018-2023) Figure Europe Diabetic Gastroparesis Treatment Revenue Market Share Forecast by Type (2018-2023) Table Europe Diabetic Gastroparesis Treatment Price (USD/Unit) Forecast by Type (2018-2023) Table Europe Diabetic Gastroparesis Treatment Sales (K Units) Forecast by Application (2018-2023) Figure Europe Diabetic Gastroparesis Treatment Sales Market Share Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Janssen Global Services, LLC Evoke Pharma Cardinal Health, Inc. Salix Pharmaceuticals, Inc. Alfa Wassermann SPA Abbott Laboratories Medtronic Plc. C. R. Bard, Inc. Rhythm Pharmaceuticals, Inc. Boston Scientific Corporation Kimberly-Clark Corporation